MIBG Therapy for Pheochromocytomas and Paragangliomas
2 vistas
• 07/02/23
0
0
Empotrar
administrator
Suscriptores
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios